Group | ES1 group(n = 20) | ES2 group(n = 18) | H1 group(n = 19) | H2 group(n = 19) | P value |
---|---|---|---|---|---|
Age (yr) | 6.5[3.0-8.8] | 3.0[2.0–6.0] | 3.0[2.0–6.0] | 4.0[3.0–8.0] | 0.274 |
Height (cm) | 124.0[97.0-139.8] | 100.0[91.5-117.5] | 102.0[96.0-120.0] | 108.0[95.0-135.0] | 0.297 |
Weight (kg) | 24.5[15.0-39.8] | 19.0[14.3–25.3] | 17.0[15.0–25.0] | 18.0[16.0–35.0] | 0.404 |
ASA status ( I/II), N | 17/3 | 15/3 | 15/4 | 15/4 | 0.957 |
Remifentanil consumption (ug) | 358.0[191.0-536.8] | 346.5[245.8-488.8] | 394.0[228.0-500.0] | 300.0[234.0-550.0] | 0.965 |
Blood loss (ml) | 5.0[4.0–6.0] | 5.0[3.8–8.3] | 5.0[3.0–6.0] | 3.0[3.0–5.0] | 0.073 |
Infusion volume (ml/h) | 135.7[99.2-203.4] | 107.5[89.9-131.5] | 104.3[83.9-134.3] | 121.6[68.2-160.7] | 0.251 |
Type of surgery | Â | 0.548 | |||
Penile or urethroplasty (I/II), N | 7/1 | 6/0 | 4/1 | 5/1 | Â |
Penile correction (I/II), N | 5/0 | 1/0 | 4/0 | 4/0 | Â |
Penile or urethroplasty combined with penile straightening (I/II), N | 5/2 | 7/1 | 6/0 | 6/1 | Â |
Laparoscopic pyeloplasty (I/II), N | 0/0 | 1/2 | 1/3 | 0/2 | Â |